AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2025

Aug 12, 2025

30339_dirs_2025-08-12_09efa0f3-f57c-494f-9b2e-256019e4047d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2025-08-04

Reporting Person: McMahon Robert W. (SVP & Chief Financial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Ownership
Rst. Stock Unit	$0		Common Stock (3168)	Direct
Rst. Stock Unit	$0		Common Stock (12670)	Direct
Stock Option (Right to Buy)	$240.33	2035-08-11	Common Stock (7647)	Direct
Stock Option (Right to Buy)	$240.33	2035-08-11	Common Stock (7137)	Direct

Footnotes

F1: This award vests in four equal installments beginning on August 11, 2026.

F2: This award vests in three installments. 4,223 shares will vest six months from the grant date, 6,335 shares will vest 12 months from the grant date, and 2,112 shares will vest 24 months from the grant date.